EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77 million samples

Esther M Maier iD, Ulrike Mütze, Nils Janzen, Ulrike Steuerwald, Uta Nennstiel, Birgit Odenwald, Elfriede Schuhmann, Amelie S Lotz-Havla, Katharina J Weiss, Johanna Hammersen, Corina Weigel, Eva Thimm und 13 weitere

Journal of Inherited Metabolic Disease · 2023

DOI: 10.1002/jimd.12671 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2023. Verfasst von Esther M Maier und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Inborn Errors of Metabolism, Dr. von Hauner Children's Hospital, Munich, Germany. Hauptthemen laut MEDLINE: Propionic Acidemia, Metabolism, Inborn Errors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dietmar Hopp Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Analytical and therapeutic innovations led to a continuous but variable extension of newborn screening (NBS) programmes worldwide. Every extension requires a careful evaluation of feasibility, diagnostic (process) quality and possible health benefits to balance benefits and limitations. The aim of this study was to evaluate the suitability of 18 candidate diseases for inclusion in NBS programmes. Utilising tandem mass spectrometry as well as establishing specific diagnostic pathways with second‐tier analyses, three German NBS centres designed and conducted an evaluation study for 18 candidate diseases, all of them inherited metabolic diseases. In total, 1 777 264 NBS samples were analysed. Overall, 441 positive NBS results were reported resulting in 68 confirmed diagnoses, 373 false‐positive cases and an estimated cumulative prevalence of approximately 1 in 26 000 newborns. The positive predictive value ranged from 0.07 (carnitine transporter defect) to 0.67 (HMG‐CoA lyase deficiency). Three individuals were missed and 14 individuals (21%) developed symptoms before the positive NBS results were reported. The majority of tested candidate diseases were found to be suitable for inclusion in NBS programmes, while multiple acyl‐CoA dehydrogenase deficiency, isolated methylmalonic acidurias, propionic acidemia and malonyl‐CoA decarboxylase deficiency showed some and carnitine transporter defect significant limitations. Evaluation studies are an important tool to assess the potential benefits and limitations of expanding NBS programmes to new diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Propionic AcidemiaMetabolism, Inborn ErrorsHumansInfant, NewbornNeonatal ScreeningTandem Mass SpectrometryCarnitine

Stichwörter der Autor:innen

Germanydried blood spotevaluation studyinborn errors of metabolismnewborn screeningpublic healthtandem mass spectrometry

Substanzen

Carnitine

Autor:innen und Institutionen

  • Department of Inborn Errors of Metabolism, Dr. von Hauner Children's Hospital, Munich, Germany.
  • Center for Pediatric and Adolescent Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Screening-Labor Hanover, Hanover, Germany.
  • Department of Clinical Chemistry, Hanover Medical School, Hanover, Germany.
  • Division of Laboratory Medicine, Centre for Children and Adolescents, Kinder- und Jugendkrankenhaus Auf der Bult, Hanover, Germany.
  • Bavarian Health and Food Safety Authority, Oberschleissheim, Germany.

ORCID-Profile: Esther M Maier

Förderung

  • Dietmar Hopp Stiftung

Zitieren

APA

Maier, E. M., Mütze, U., Janzen, N., Steuerwald, U., Nennstiel, U., Odenwald, B., Schuhmann, E., Lotz-Havla, A. S., Weiss, K. J., Hammersen, J., Weigel, C., Thimm, E., Grünert, S. C., Hennermann, J. B., Freisinger, P., Krämer, J., Das, A. M., Illsinger, S., Gramer, G., …, & Röschinger, W. (2023). Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77 million samples. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12671

Vancouver

Maier EM, Mütze U, Janzen N, Steuerwald U, Nennstiel U, Odenwald B, et al. Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77 million samples. Journal of Inherited Metabolic Disease. 2023. doi:10.1002/jimd.12671

BibTeX
@article{Maier2023,
  author = {Maier, Esther M and Mütze, Ulrike and Janzen, Nils and Steuerwald, Ulrike and Nennstiel, Uta and Odenwald, Birgit and Schuhmann, Elfriede and Lotz-Havla, Amelie S and Weiss, Katharina J and Hammersen, Johanna and Weigel, Corina and Thimm, Eva and Grünert, Sarah C and Hennermann, Julia B and Freisinger, Peter and Krämer, Johannes and Das, Anibh M and Illsinger, Sabine and Gramer, Gwendolyn and Fang-Hoffmann, Junmin and Garbade, Sven F and Okun, Jürgen G and Hoffmann, Georg F and Kölker, Stefan and Röschinger, Wulf},
  title = {Collaborative evaluation study on 18 candidate diseases for newborn screening in 1.77 million samples},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2023},
  doi = {10.1002/jimd.12671}
}
Kostenlos starten →